FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Lorena Landuzzi

Research Profile

Living Beings

Disorders

Anatomy

Chemicals & Drugs

Physiology

Procedures

Neoplasm Transplantation

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Patrizia Nanni; Giordano Nicoletti; Arianna Palladini; Laura Menotti; Gabriella Campadelli-Fiume; Stefania Croci; Massimiliano Dall'ora; Carla De Giovanni; Valentina Gatta; Valentina Grosso; Marianna Ianzano; Manuela Iezzi; Lorena Landuzzi; Pier-Luigi Lollini
Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.
Carla De Giovanni; V Grosso; M L Ianzano; Manuela Iezzi; Lorena Landuzzi; R M Lemoli; A Murgo; Patrizia Nanni; G Nicoletti; Arianna Palladini; F Romani; V Stivani; L Stramucci; A Antognoli; E Barbieri; Stefania Croci; Pier-Luigi Lollini
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice.
Patrizia Nanni; Giordano Nicoletti; Arianna Palladini; Valeria Stivani; Annalisa Murgo; Agnese Antognoli; Stefania Croci; Carla De Giovanni; Emmanuelle di Tomaso; Valentina Grosso; Marianna L Ianzano; Manuela Iezzi; Alessia Lamolinara; Lorena Landuzzi; Pier-Luigi Lollini
Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Lorena Landuzzi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Patrizia Nanni; Giordano Nicoletti; Arianna Palladini; Laura Menotti; Gabriella Campadelli-Fiume; Stefania Croci; Massimiliano Dall'ora; Carla De Giovanni; Valentina Gatta; Valentina Grosso; Marianna Ianzano; Manuela Iezzi; Lorena Landuzzi; Pier-Luigi Lollini
Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.
PLoS pathogens 2013;9(1):e1003155.
2012: Carla De Giovanni; V Grosso; M L Ianzano; Manuela Iezzi; Lorena Landuzzi; R M Lemoli; A Murgo; Patrizia Nanni; G Nicoletti; Arianna Palladini; F Romani; V Stivani; L Stramucci; A Antognoli; E Barbieri; Stefania Croci; Pier-Luigi Lollini
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice.
British journal of cancer 2012;107(8):1302-9.
2012: Patrizia Nanni; Giordano Nicoletti; Arianna Palladini; Valeria Stivani; Annalisa Murgo; Agnese Antognoli; Stefania Croci; Carla De Giovanni; Emmanuelle di Tomaso; Valentina Grosso; Marianna L Ianzano; Manuela Iezzi; Alessia Lamolinara; Lorena Landuzzi; Pier-Luigi Lollini
Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor.
PloS one 2012;7(6):e39626.
2011: Lorena Landuzzi; Agnese Antognoli; Stefania Croci; Carla De Giovanni; Valentina Grosso; Marianna Lucia Ianzano; Annalisa Murgo; Patrizia Nanni; Giordano Nicoletti; Arianna Palladini; Valeria Stivani; Pier-Luigi Lollini
HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines.
Vaccine 2011;29(29-30):4690-7.
2011: Tobias Mueck; Felicitas Berger; Ingrid Buechsler; Ralitsa S Valchanova; Lorena Landuzzi; Pier-Luigi Lollini; Karin Klingel; Barbara Munz
TRAF6 regulates proliferation and differentiation of skeletal myoblasts.
Differentiation; research in biological diversity 2011;81(2):99-106.
2011: Michela Pasello; Piero Picci; Katia Scotlandi; Annamaria Caccuri; Marilù Fanelli; Claudia M Hattinger; Lorena Landuzzi; Pier-Luigi Lollini; Maria Cristina Manara; Francesca Michelacci; Giordano Nicoletti; Massimo Serra
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy.
Analytical cellular pathology (Amsterdam) 2011;34(3):131-45.
2010: Maria A Pantaleo; Eyal Mishani; Cristina Nanni; Lorena Landuzzi; Stefano Boschi; Giordano Nicoletti; Samar Dissoki; Paola Paterini; Pier Poalo Piccaluga; Filippo Lodi; Pier-Luigi Lollini; Stefano Fanti; Guido Biasco
Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2010;12(6):616-25.
2010: Stefania Croci; Christian V Recktenwald; Rudolf Lichtenfels; Giordano Nicoletti; Sven P Dressler; Carla De Giovanni; Annalisa Astolfi; Arianna Palladini; Kazuo Shin-Ya; Lorena Landuzzi; Patrizia Nanni; Pier-Luigi Lollini; Barbara Seliger
Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system.
Proteomics 2010;10(21):3835-53.
2010: Arianna Palladini; Giordano Nicoletti; Francesco Pappalardo; Annalisa Murgo; Valentina Grosso; Valeria Stivani; Marianna L Ianzano; Agnese Antognoli; Stefania Croci; Lorena Landuzzi; Carla De Giovanni; Patrizia Nanni; Santo Motta; Pier-Luigi Lollini
In silico modeling and in vivo efficacy of cancer-preventive vaccinations.
Cancer research 2010;70(20):7755-63.
2010: Pier-Luigi Lollini; Giordano Nicoletti; Lorena Landuzzi; Carla De Giovanni; Patrizia Nanni
Immunoprevention and immunotherapy of mammary carcinoma.
The breast journal 2010;16 Suppl 1():S39-41.
2010: Patrizia Nanni; Giordano Nicoletti; Lorena Landuzzi; Stefania Croci; Annalisa Murgo; Arianna Palladini; Agnese Antognoli; Marianna L Ianzano; Valeria Stivani; Valentina Grosso; Sauveur-Michel Maira; Carlos García-Echeverría; Katia Scotlandi; Carla De Giovanni; Pier-Luigi Lollini
High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.
European journal of cancer (Oxford, England : 1990) 2010;46(3):659-68.
2010: Maria Cristina Manara; Giordano Nicoletti; Diana Zambelli; Selena Ventura; Clara Guerzoni; Lorena Landuzzi; Pier-Luigi Lollini; Saveur-Michel Maira; Carlos García-Echeverría; Mario Mercuri; Piero Picci; Katia Scotlandi
NVP-BEZ235 as a new therapeutic option for sarcomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(2):530-40.
2010: Maria Abbondanza Pantaleo; Giordano Nicoletti; Cristina Nanni; Chiara Gnocchi; Lorena Landuzzi; Carmelo Quarta; Stefano Boschi; Margherita Nannini; Monica Di Battista; paolo castellucci; Stefano Fanti; Pier-Luigi Lollini; Elena Bellan; Mauro Castelli; Domenico Rubello; Guido Biasco
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET.
Journal of experimental & clinical cancer research : CR 2010;29():173.
2010: Diana Zambelli; Monia Zuntini; Filippo Nardi; Maria Cristina Manara; Massimo Serra; Lorena Landuzzi; Pier-Luigi Lollini; Stefano Ferrari; Marco Alberghini; Antonio Llombart Bosch; Enza Piccolo; Stefano Iacobelli; Piero Picci; Katia Scotlandi
Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP).
International journal of cancer. Journal international du cancer 2010;126(1):41-52.
2009: Carla De Giovanni; Lorena Landuzzi; Giordano Nicoletti; Pier-Luigi Lollini; Patrizia Nanni
Molecular and cellular biology of rhabdomyosarcoma.
Future oncology (London, England) 2009;5(9):1449-75.
2009: Stewart Sale; Isabel L Fong; Carla de Giovanni; Lorena Landuzzi; Karen Brown; William P Steward; Andreas J Gescher
APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the Apc(Min) mouse model in vivo.
European journal of cancer (Oxford, England : 1990) 2009;45(16):2731-5.
2009: Laura Menotti; Giordano Nicoletti; Valentina Gatta; Stefania Croci; Lorena Landuzzi; Carla De Giovanni; Patrizia Nanni; Pier-Luigi Lollini; Gabriella Campadelli-Fiume
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(22):9039-44.
2009: Carla De Giovanni; Giordano Nicoletti; Arianna Palladini; Stefania Croci; Lorena Landuzzi; A Antognoli; A Murgo; Annalisa Astolfi; Silvano Ferrini; M Fabbi; Anna Maria Orengo; Augusto Amici; M L Penichet; L Aurisicchio; Manuela Iezzi; Piero Musiani; Patrizia Nanni; Pier-Luigi Lollini
A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome.
Human gene therapy 2009;20(5):453-64.
2009: Carla De Giovanni; Giordano Nicoletti; Lorena Landuzzi; Stefania Croci; Arianna Palladini; Agnese Antognoli; Annalisa Murgo; Marianna L Ianzano; Valentina Grosso; Valeria Stivani; Manuela Iezzi; Piero Musiani; Patrizia Nanni; Pier-Luigi Lollini
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.
Vaccine 2009;27(14):2065-9.
2009: Maria Abbondanza Pantaleo; M Nannini; A Maleddu; Stefano Fanti; Cristina Nanni; S Boschi; F Lodi; G Nicoletti; Lorena Landuzzi; P L Lollini; G Biasco
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(2):213-26.
2008: Anna C Berardi; Sonia Marsilio; Cristina Rofani; Ombretta Salvucci; Pierluigi Altavista; Francesco M Perla; Francesca Diomedi-Camassei; Stefania Uccini; George Kokai; Lorena Landuzzi; Heather P McDowell; Carlo Dominici
Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma.
Anticancer research 2008;28(2A):763-9.
2008: Svenja Ehlers; Tobias Mueck; Stephanie Adams; Lorena Landuzzi; Pier-Luigi Lollini; Barbara Munz
RIP2 regulates growth and differentiation of normal myoblasts and of rhabdomyosarcoma cells.
European journal of cell biology 2008;87(3):163-72.
2007: Patrizia Nanni; Giordano Nicoletti; Arianna Palladini; Stefania Croci; Annalisa Murgo; Agnese Antognoli; Lorena Landuzzi; Marina Fabbi; Silvano Ferrini; Piero Musiani; Manuela Iezzi; Carla De Giovanni; Pier-Luigi Lollini
Antimetastatic activity of a preventive cancer vaccine.
Cancer research 2007;67(22):11037-44.
2007: Stefania Croci; Giordano Nicoletti; Lorena Landuzzi; Arianna Palladini; Francesca Chiarini; Patrizia Nanni; Pier-Luigi Lollini; Carla De Giovanni
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.
Oncology reports 2007;18(2):451-6.
2007: Carla De Giovanni; Stefania Croci; Giordano Nicoletti; Lorena Landuzzi; Arianna Palladini; Tania Pannellini; Ludovica Borgia; Manuela Iezzi; Emma Di Carlo; Anna Maria Orengo; Ronald C Kennedy; Pier-Luigi Lollini; Patrizia Nanni; Piero Musiani
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis.
International journal of cancer. Journal international du cancer 2007;121(1):88-94.
2007: Maria Cristina Manara; Lorena Landuzzi; Patrizia Nanni; Giordano Nicoletti; Diana Zambelli; Pier-Luigi Lollini; Cristina Nanni; Francesco Hofmann; Carlos García-Echeverría; Piero Picci; Katia Scotlandi
Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1322-30.
2007: Stefania Croci; Lorena Landuzzi; Giordano Nicoletti; Arianna Palladini; Agnese Antognoli; Carla De Giovanni; Patrizia Nanni; Pier-Luigi Lollini
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis.
Pathology oncology research : POR 2007;13(4):336-9.
2006: Maria Cristina Manara; Ghislaine Bernard; Pier-Luigi Lollini; Patrizia Nanni; Monia Zuntini; Lorena Landuzzi; Stefania Benini; Giovanna Lattanzi; Marika Sciandra; Massimo Serra; Mario P Colombo; Alain Bernard; Piero Picci; Katia Scotlandi
CD99 acts as an oncosuppressor in osteosarcoma.
Molecular biology of the cell 2006;17(4):1910-21.
2006: Arianna Palladini; Annalisa Astolfi; Stefania Croci; Carla De Giovanni; Giordano Nicoletti; Angelo Rosolen; Francesca Sartori; Pier-Luigi Lollini; Lorena Landuzzi; Patrizia Nanni
Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine role.
European journal of cancer (Oxford, England : 1990) 2006;42(5):680-7.
2005: F Casadio; Stefania Croci; Antonia D'Errico-Grigioni; Barbara Corti; Walter Franco Grigioni; Lorena Landuzzi; Pier-Luigi Lollini
Toward the definition of immunosuppressive regimens with antitumor activity.
Transplantation proceedings 2005;37(5):2144-7.
2005: P-L Lollini; G Nicoletti; Lorena Landuzzi; Carla De Giovanni; Patrizia Nanni
New target antigens for cancer immunoprevention.
Current cancer drug targets 2005;5(3):221-8.
2005: Annalisa Astolfi; Lorena Landuzzi; Giordano Nicoletti; Carla De Giovanni; Stefania Croci; Arianna Palladini; Silvano Ferrini; Manuela Iezzi; Piero Musiani; Federica Cavallo; Guido Forni; Patrizia Nanni; Pier-Luigi Lollini
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.
The American journal of pathology 2005;166(4):1205-16.
2004: Stefania Croci; Giordano Nicoletti; Lorena Landuzzi; Carla De Giovanni; Annalisa Astolfi; Chiara Marini; Emma Di Carlo; Piero Musiani; Guido Forni; Patrizia Nanni; Pier-Luigi Lollini
Immunological prevention of a multigene cancer syndrome.
Cancer research 2004;64(22):8428-34.
2004: Patrizia Nanni; Lorena Landuzzi; Giordano Nicoletti; Carla De Giovanni; Ilaria Rossi; Stefania Croci; Annalisa Astolfi; Manuela Iezzi; Emma Di Carlo; Piero Musiani; Guido Forni; Pier-Luigi Lollini
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(4):2288-96.
2004: Carla De Giovanni; Giordano Nicoletti; Lorena Landuzzi; Annalisa Astolfi; Stefania Croci; Alberto Comes; Silvano Ferrini; Raffaella Meazza; Manuela Iezzi; Emma Di Carlo; Piero Musiani; Federica Cavallo; Patrizia Nanni; Pier-Luigi Lollini
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine.
Cancer research 2004;64(11):4001-9.
2004: Carla De Giovanni; Lorena Landuzzi; Giordano Nicoletti; Annalisa Astolfi; Stefania Croci; Massimo Micaroni; Patrizia Nanni; Pier-Luigi Lollini
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity.
International journal of cancer. Journal international du cancer 2004;109(2):200-6.
2004: Stefania Croci; Lorena Landuzzi; Annalisa Astolfi; Giordano Nicoletti; Angelo Rosolen; Francesca Sartori; Matilde Y Follo; Noelynn Oliver; Carla De Giovanni; Patrizia Nanni; Pier-Luigi Lollini
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells.
Cancer research 2004;64(5):1730-6.
2003: Patrizia Nanni; Giordano Nicoletti; Carla De Giovanni; Lorena Landuzzi; Emma Di Carlo; Manuela Iezzi; Cinzia Ricci; Annalisa Astolfi; Stefania Croci; Francesco Marangoni; Piero Musiani; Guido Forni; Pier-Luigi Lollini
Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12.
International journal of cancer. Journal international du cancer 2003;105(3):384-9.
2003: Patrizia Nanni; Giordano Nicoletti; Carla De Giovanni; Stefania Croci; Annalisa Astolfi; Lorena Landuzzi; Emma Di Carlo; Manuela Iezzi; Piero Musiani; Pier-Luigi Lollini
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.
Cancer research 2003;63(11):2728-32.
2003: Katia Scotlandi; Maria Cristina Manara; Rosaria Strammiello; Lorena Landuzzi; Stefania Benini; Stefania Perdichizzi; Massimo Serra; Annalisa Astolfi; Giordano Nicoletti; Pier-Luigi Lollini; Franco Bertoni; Patrizia Nanni; Piero Picci
C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(10):1952-60.
2002: Katia Scotlandi; Sofia Avnet; Stefania Benini; Maria Cristina Manara; Massimo Serra; Vanessa Cerisano; Stefania Perdichizzi; Pier-Luigi Lollini; Carla De Giovanni; Lorena Landuzzi; Piero Picci
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells.
International journal of cancer. Journal international du cancer 2002;101(1):11-6.
2002: Cinzia Ricci; Letizia Polito; Patrizia Nanni; Lorena Landuzzi; Annalisa Astolfi; Giordano Nicoletti; Ilaria Rossi; Carla De Giovanni; Andrea Bolognesi; Pier-Luigi Lollini
HER/erbB receptors as therapeutic targets of immunotoxins in human rhabdomyosarcoma cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2002;25(4):314-23.
2001: Patrizia Nanni; Giordano Nicoletti; Carla De Giovanni; Lorena Landuzzi; Emma Di Carlo; Federica Cavallo; Serenella M Pupa; Ilaria Rossi; Mario P Colombo; Cinzia Ricci; Annalisa Astolfi; Piero Musiani; Guido Forni; Pier-Luigi Lollini
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice.
The Journal of experimental medicine 2001;194(9):1195-205.
2001: Carla De Giovanni; Giordano Nicoletti; Lorena Landuzzi; Ilaria Rossi; Annalisa Astolfi; Cinzia Ricci; E Di Carlo; Piero Musiani; Guido Forni; D Fradelizi; Patrizia Nanni; Pier-Luigi Lollini
Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gamma.
Gene therapy 2001;8(22):1698-704.
2001: Annalisa Astolfi; Patrizia Nanni; Lorena Landuzzi; Cinzia Ricci; Giordano Nicoletti; Ilaria Rossi; Pier-Luigi Lollini; Carla De Giovanni
An anti-apoptotic role for NGF receptors in human rhabdomyosarcoma.
European journal of cancer (Oxford, England : 1990) 2001;37(13):1719-25.
2001: Annalisa Astolfi; Carla De Giovanni; Lorena Landuzzi; Giordano Nicoletti; Cinzia Ricci; Stefania Croci; L Scopece; Patrizia Nanni; Pier-Luigi Lollini
Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells.
Gene 2001;274(1-2):139-49.
2000: Lorena Landuzzi; Carla De Giovanni; Giordano Nicoletti; Ilaria Rossi; Cinzia Ricci; Annalisa Astolfi; L Scopece; Katia Scotlandi; Massimo Serra; Gian Paolo Bagnara; Patrizia Nanni; Pier-Luigi Lollini
The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit.
The American journal of pathology 2000;157(6):2123-31.
2000: Katia Scotlandi; Stefania Benini; Maria Cristina Manara; Massimo Serra; Patrizia Nanni; Pier-Luigi Lollini; Giordano Nicoletti; Lorena Landuzzi; Tokuhiro Chano; Piero Picci; Nicola Baldini
Murine model for skeletal metastases of Ewing's sarcoma.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2000;18(6):959-66.
2000: Stefania Rovero; Augusto Amici; E Di Carlo; Roberto Bei; Patrizia Nanni; Elena Quaglino; Paola Porcedda; Katia Boggio; Arianna Smorlesi; Pier-Luigi Lollini; Lorena Landuzzi; Mario P Colombo; Mirella Giovarelli; Piero Musiani; Guido Forni
DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(9):5133-42.
2000: Patrizia Nanni; Serenella M Pupa; Giordano Nicoletti; Carla De Giovanni; Lorena Landuzzi; Ilaria Rossi; Annalisa Astolfi; Cinzia Ricci; R De Vecchi; Annamaria Invernizzi; Emma Di Carlo; Piero Musiani; Guido Forni; S Menard; Pier-Luigi Lollini
p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma.
International journal of cancer. Journal international du cancer 2000;87(2):186-94.
2000: Cinzia Ricci; Lorena Landuzzi; Ilaria Rossi; Carla De Giovanni; Giordano Nicoletti; Annalisa Astolfi; Serenella M Pupa; S Menard; Katia Scotlandi; Patrizia Nanni; Pier-Luigi Lollini
Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells.
International journal of cancer. Journal international du cancer 2000;87(1):29-36.
1998: Carla De Giovanni; Patrizia Nanni; Ada Sacchi; Silvia Soddu; Isabella Manni; Gabriella D'Orazi; S Bulfone-Paus; T Pohl; Lorena Landuzzi; Giordano Nicoletti; Flavia Frabetti; Ilaria Rossi; Pier-Luigi Lollini
Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cells.
British journal of cancer 1998;78(12):1541-6.
1998: Lorena Landuzzi; Pierluigi Strippoli; Carla De Giovanni; Giordano Nicoletti; Ilaria Rossi; Roberto Tonelli; Flavia Frabetti; Patrizia Nanni; Gian Paolo Bagnara; Pier-Luigi Lollini
Production of stem cell factor and expression of c-kit in human rhabdomyosarcoma cells: lack of autocrine growth modulation.
International journal of cancer. Journal international du cancer 1998;78(4):441-5.
1998: Katia Scotlandi; Stefania Benini; Patrizia Nanni; Pier-Luigi Lollini; Giordano Nicoletti; Lorena Landuzzi; Massimo Serra; Maria Cristina Manara; Piero Picci; Nicola Baldini
Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice.
Cancer research 1998;58(18):4127-31.
1998: Pier-Luigi Lollini; Giordano Nicoletti; Lorena Landuzzi; Carla De Giovanni; Ilaria Rossi; Emma Di Carlo; Piero Musiani; W J Muller; Patrizia Nanni
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice.
International journal of cancer. Journal international du cancer 1998;77(6):937-41.
1998: Katia Boggio; Giordano Nicoletti; Emma Di Carlo; Federica Cavallo; Lorena Landuzzi; Cecilia Melani; Mirella Giovarelli; Ilaria Rossi; Patrizia Nanni; Carla De Giovanni; P Bouchard; Stanley Wolf; Andrea Modesti; Piero Musiani; Pier-Luigi Lollini; Mario P Colombo; Guido Forni
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.
The Journal of experimental medicine 1998;188(3):589-96.
1998: Pier-Luigi Lollini; Lorena Landuzzi; Flavia Frabetti; Ilaria Rossi; Giordano Nicoletti; Katia Scotlandi; Massimo Serra; Nicola Baldini; Carla De Giovanni; Patrizia Nanni
Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(8):1843-9.
1998: Patrizia Nanni; Ilaria Rossi; Carla De Giovanni; Lorena Landuzzi; Giordano Nicoletti; Antonella Stoppacciaro; Mariella Parenza; Mario P Colombo; Pier-Luigi Lollini
Interleukin 12 gene therapy of MHC-negative murine melanoma metastases.
Cancer research 1998;58(6):1225-30.
1998: Ilaria Rossi; Giordano Nicoletti; Lorena Landuzzi; Flavia Frabetti; Carla De Giovanni; Patrizia Nanni; Piero Musiani; Maria Ferrantini; F Belardelli; Pier-Luigi Lollini
Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-alpha gene-transduced tumor cells.
Clinical & experimental metastasis 1998;16(2):123-8.
1998: Patrizia Nanni; Carla De Giovanni; Giordano Nicoletti; Lorena Landuzzi; Ilaria Rossi; Flavia Frabetti; Mirella Giovarelli; Guido Forni; Federica Cavallo; Emma Di Carlo; Piero Musiani; Pier-Luigi Lollini
The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cells.
Human gene therapy 1998;9(2):217-24.
1997: Pier-Luigi Lollini; G Palmieri; Carla De Giovanni; Lorena Landuzzi; Giordano Nicoletti; Ilaria Rossi; Cristiana Griffoni; Flavia Frabetti; Katia Scotlandi; Stefania Benini; Nicola Baldini; A Santoni; Patrizia Nanni
Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma.
International journal of cancer. Journal international du cancer 1997;71(5):732-6.
1997: Emma Di Carlo; Andrea Modesti; Graziella Castrilli; Lorena Landuzzi; A Allione; C de Giovanni; T Musso; Piero Musiani
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential.
The Journal of pathology 1997;182(1):76-85.
1996: Patrizia Nanni; Carla De Giovanni; Lorena Landuzzi; Giordano Nicoletti; Flavia Frabetti; Ilaria Rossi; Federica Cavallo; Mirella Giovarelli; Guido Forni; Pier-Luigi Lollini
Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells.
British journal of cancer 1996;74(10):1564-9.
1996: Lorena Landuzzi; Flavia Frabetti; Ilaria Rossi; Cristiana Griffoni; Carla De Giovanni; Giordano Nicoletti; Patrizia Nanni; R Miniero; G Palmieri; A Santoni; Pier-Luigi Lollini
Expression of transduced carcinoembryonic antigen gene in human rhabdomyosarcoma inhibits metastasis.
Cancer research 1996;56(19):4503-8.
1996: Carla De Giovanni; Lorena Landuzzi; Flavia Frabetti; Giordano Nicoletti; Cristiana Griffoni; Ilaria Rossi; M Mazzotti; L Scotto; Patrizia Nanni; Pier-Luigi Lollini
Antisense epidermal growth factor receptor transfection impairs the proliferative ability of human rhabdomyosarcoma cells.
Cancer research 1996;56(17):3898-901.
1996: Pier-Luigi Lollini; Patrizia Nanni; Carla De Giovanni; G Nicoletti; Lorena Landuzzi
Re:Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study.
Journal of the National Cancer Institute 1996;88(13):926-7.
1996: Katia Scotlandi; Massimo Serra; Giordano Nicoletti; M Vaccari; Maria Cristina Manara; G Nini; Lorena Landuzzi; A Colacci; Gaetano Bacci; F Bertoni; Piero Picci; M Campanacci; Nicola Baldini
Multidrug resistance and malignancy in human osteosarcoma.
Cancer research 1996;56(10):2434-9.
1995: Carla De Giovanni; Cecilia Melani; Patrizia Nanni; Lorena Landuzzi; Giordano Nicoletti; Flavia Frabetti; Cristiana Griffoni; Mario P Colombo; Pier-Luigi Lollini
Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin.
British journal of cancer 1995;72(5):1224-9.
1995: Pier-Luigi Lollini; Carla De Giovanni; Lorena Landuzzi; Giordano Nicoletti; Flavia Frabetti; Federica Cavallo; Mirella Giovarelli; Guido Forni; Anna Modica; Andrea Modesti
Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth.
Human gene therapy 1995;6(6):743-52.
1995: Pier-Luigi Lollini; A D'Errico; Carla De Giovanni; Lorena Landuzzi; Flavia Frabetti; Giordano Nicoletti; Federica Cavallo; Mirella Giovarelli; Walter Franco Grigioni; Patrizia Nanni
Systemic effects of cytokines released by gene-transduced tumor cells: marked hyperplasia induced in small bowel by gamma-interferon transfectants through host lymphocytes.
International journal of cancer. Journal international du cancer 1995;61(3):425-30.
1994: Carla De Giovanni; Giordano Nicoletti; M Sensi; A Santoni; G Palmieri; Lorena Landuzzi; Patrizia Nanni; Pier-Luigi Lollini
H-2Kb and H-2Db gene transfections in B16 melanoma differently affect non-immunological properties relevant to the metastatic process. Involvement of integrin molecules.
International journal of cancer. Journal international du cancer 1994;59(2):269-74.
1993: D Lauri; Carla De Giovanni; T Biondelli; E Lalli; Lorena Landuzzi; Andrea Facchini; Giordano Nicoletti; Patrizia Nanni; Elisabetta Dejana; Pier-Luigi Lollini
Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells.
British journal of cancer 1993;68(5):862-7.
1993: Pier-Luigi Lollini; M C Bosco; Federica Cavallo; Carla De Giovanni; Mirella Giovarelli; Lorena Landuzzi; Piero Musiani; Andrea Modesti; Giordano Nicoletti; G Palmieri
Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene.
International journal of cancer. Journal international du cancer 1993;55(2):320-9.
1993: Carla De Giovanni; Pier-Luigi Lollini; R Dolcetti; Lorena Landuzzi; Giordano Nicoletti; Emma D'Andrea; K Scotland; Patrizia Nanni
Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.
British journal of cancer 1993;67(4):674-9.
1992: Pier-Luigi Lollini; Lorena Landuzzi; Giordano Nicoletti; Carla De Giovanni; Mirella Giovarelli; E Lalli; Andrea Facchini; Patrizia Nanni
Ly-6A/E gene is widely expressed among transformed nonhematopoietic cells. Autocrine modulation by interferon.
Anticancer research 1992;12(6B):2245-52.
1992: Patrizia Nanni; Lorena Landuzzi; Giordano Nicoletti; Carla De Giovanni; Mirella Giovarelli; E Lalli; Andrea Facchini; Pier-Luigi Lollini
Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon.
British journal of cancer 1992;66(3):479-82.
1992: Katia Scotlandi; M Serra; Lorena Landuzzi; Nicola Baldini
SARG: a new human osteosarcoma cell line. Expression of bone markers and of major histocompatibility antigens.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 2():S29-31.
1992: Giordano Nicoletti; Carla De Giovanni; Lorena Landuzzi; G Simone; Paola Rocchi; Patrizia Nanni; Pier-Luigi Lollini
Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.
British journal of cancer 1992;65(4):519-22.
1991: Carla De Giovanni; G Palmieri; Giordano Nicoletti; Lorena Landuzzi; Katia Scotlandi; Andrea Bontadini; Pier Luigi Tazzari; M Sensi; A Santoni; Patrizia Nanni
Immunological and non-immunological influence of H-2Kb gene transfection on the metastatic ability of B16 melanoma cells.
International journal of cancer. Journal international du cancer 1991;48(2):270-6.
1991: Patrizia Nanni; Giuseppe Azzarello; L Tessarollo; Carla De Giovanni; Pier-Luigi Lollini; Giordano Nicoletti; Katia Scotlandi; Lorena Landuzzi; MP Panozzo; Emma D'Andrea
In vitro differentiation of rhabdomyosarcomas induced by nickel or by Moloney murine sarcoma virus.
British journal of cancer 1991;63(5):736-42.
1991: Pier-Luigi Lollini; Carla De Giovanni; Lorena Landuzzi; Giordano Nicoletti; Katia Scotlandi; Patrizia Nanni
Reduced metastatic ability of in vitro differentiated human rhabdomyosarcoma cells.
Invasion & metastasis 1991;11(2):116-24.
1990: Pier-Luigi Lollini; Carla De Giovanni; Giordano Nicoletti; Andrea Bontadini; Pier Luigi Tazzari; Lorena Landuzzi; Katia Scotlandi; Patrizia Nanni
Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma.
Clinical & experimental metastasis 1990;8(2):215-24.
1989: Carla De Giovanni; Patrizia Nanni; Giordano Nicoletti; Claudio Ceccarelli; Katia Scotlandi; Lorena Landuzzi; Pier-Luigi Lollini
Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA).
Anticancer research 1989;9(6):1943-9.
1989: Giordano Nicoletti; Carla De Giovanni; Pier-Luigi Lollini; Gian Paolo Bagnara; Katia Scotlandi; Lorena Landuzzi; B del Re; giorgio zauli; G Prodi; Patrizia Nanni
In vivo and in vitro production of haemopoietic colony-stimulating activity by murine cell lines of different origin: a frequent finding.
European journal of cancer & clinical oncology 1989;25(9):1281-6.
1989: Pier-Luigi Lollini; Carla De Giovanni; Giordano Nicoletti; Katia Scotlandi; Lorena Landuzzi; Patrizia Nanni
Modulation by IFN-gamma of the metastatic ability of murine, human, and H-2-transfected tumor cells.
Tumori 1989;75(4):383-8.
1989: Pier-Luigi Lollini; Carla De Giovanni; B Del Re; Lorena Landuzzi; Giordano Nicoletti; G Prodi; Katia Scotlandi; Patrizia Nanni
Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs.
Cancer research 1989;49(13):3631-6.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.